At the beginning of our second 5-year term, the editorial leadership team met with a variety of consultants in August of 2010 at Journal headquarters in Northbrook, Illinois, for the express purpose of stocktaking. During a 2-day strategic planning meeting, we reappraised the present situation and position of the Journal as well as its short-term and long-term outlooks.
An in-depth review of data that reflected the current state of the Journal revealed that we had successfully implemented our strategic plans from 20051,2 and 2007,3 and, by doing so, we achieved our initial1,2 and interim3 goals of improving the quality of the research and scholarly articles we published, maintaining a successful financial position, and, most importantly, continuing to provide our readers with the content they expect and need. For example, in 2009, CHEST was selected as one of the 100 most influential journals in biology and medicine over the last 100 years by the Biomedical and Life Sciences Division of the Special Libraries Association4; CHEST was the only respiratory journal in the world to be so honored. During the past 5 years, our impact factor has risen quickly to its present value of 6.36 (Fig 1). By reaching this level within this brief time frame, we surpassed our goal of reaching an impact factor of 5 within 5 years, to the surprise of the pundits (see the Second Opinion editorial cartoon by Rob Rogers on page 15 in this issue of CHEST5). By benchmarking against other journals in the respiratory field, the Journal Citation Reports,6 published by Thomson Reuters Web of Knowledge (formerly ISI Web of Knowledge), demonstrates that CHEST’s impact factor now ranks third among the 43 journals listed. When self-citations are eliminated (ie, Eigenfactor Score), CHEST’s value of 0.10746 ranks second, just behind the American Journal of Respiratory and Critical Care Medicine (0.11704).